spiroquinazoline has been researched along with cyclo(prolyl-valyl) in 1 studies
| Studies (spiroquinazoline) | Trials (spiroquinazoline) | Recent Studies (post-2010) (spiroquinazoline) | Studies (cyclo(prolyl-valyl)) | Trials (cyclo(prolyl-valyl)) | Recent Studies (post-2010) (cyclo(prolyl-valyl)) |
|---|---|---|---|---|---|
| 7 | 0 | 5 | 6 | 0 | 4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrow, CJ; Sun, HH | 1 |
1 other study(ies) available for spiroquinazoline and cyclo(prolyl-valyl)
| Article | Year |
|---|---|
Spiroquinazoline, a novel substance P inhibitor with a new carbon skeleton, isolated from Aspergillus flavipes.
Topics: Antineoplastic Agents; Aspergillus; Astrocytoma; Drug Screening Assays, Antitumor; Humans; Magnetic Resonance Spectroscopy; Nervous System Neoplasms; Receptors, Neurokinin-1; Spectrophotometry, Ultraviolet; Spiro Compounds; Stereoisomerism; Substance P; Tumor Cells, Cultured | 1994 |